Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families
- PMID: 15168169
- DOI: 10.1007/s10038-004-0160-5
Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families
Abstract
We sequenced approximately 23 kb genomic regions containing all the coding exons and their franking introns of two breast cancer susceptibility genes, BRCA1 and BRCA2, of 55 individuals from 50 unrelated Japanese breast cancer families. We identified 55 single-nucleotide polymorphisms (SNPs) (21 in BRCA1 and 34 in BRCA2) containing nine pathogenic protein-truncating mutations (four in BRCA1 and five in BRCA2 from ten patients). Among the remaining 46 SNPs, allele frequencies of 40 were examined in both the breast cancer patients and 28 healthy volunteers with no breast cancer family history by PCR-RFLP or by direct DNA sequencing. Twenty-eight SNPs were common and were also found in the healthy volunteers and/or a SNP database. The remaining 18 were rare (allele frequency <0.05) and were not found in the healthy volunteers and/or the database. The pathogenic significance of these coding SNPs (cSNPs) remains to be clarified. The SNP information from this study will be useful in the future genetic testing of both BRCA1 and BRCA2 genes in the Japanese population.
Similar articles
-
Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.Breast Cancer Res Treat. 2004 Nov;88(2):177-86. doi: 10.1007/s10549-004-0593-8. Breast Cancer Res Treat. 2004. PMID: 15564800
-
[Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].Zhonghua Yi Xue Za Zhi. 2004 Feb 17;84(4):294-8. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15059511 Chinese.
-
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.Breast Cancer Res Treat. 2010 Nov;124(2):337-47. doi: 10.1007/s10549-010-0745-y. Epub 2010 Feb 5. Breast Cancer Res Treat. 2010. PMID: 20135348
-
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.Int J Cancer. 2002 Feb 1;97(4):472-80. doi: 10.1002/ijc.1626. Int J Cancer. 2002. PMID: 11802209
-
Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants.Klin Onkol. 2019 Summer;32(Supplementum2):51-71. doi: 10.14735/amko2019S51. Klin Onkol. 2019. PMID: 31409081 Review. English.
Cited by
-
Increased centrosome number in BRCA-related breast cancer specimens determined by immunofluorescence analysis.Cancer Sci. 2018 Jun;109(6):2027-2035. doi: 10.1111/cas.13595. Epub 2018 May 15. Cancer Sci. 2018. PMID: 29601120 Free PMC article.
-
K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review.Cancers (Basel). 2021 Jan 25;13(3):447. doi: 10.3390/cancers13030447. Cancers (Basel). 2021. PMID: 33503928 Free PMC article. Review.
-
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.J Med Genet. 2006 Jan;43(1):74-83. doi: 10.1136/jmg.2005.033258. Epub 2005 May 27. J Med Genet. 2006. PMID: 15923272 Free PMC article.
-
Advances in ligase chain reaction and ligation-based amplifications for genotyping assays: Detection and applications.Mutat Res Rev Mutat Res. 2017 Jul;773:66-90. doi: 10.1016/j.mrrev.2017.05.001. Epub 2017 May 2. Mutat Res Rev Mutat Res. 2017. PMID: 28927538 Free PMC article. Review.
-
Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.Cancer Sci. 2008 Oct;99(10):1967-76. doi: 10.1111/j.1349-7006.2008.00944.x. Cancer Sci. 2008. PMID: 19016756 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous